Imaging and Clinical Reports

PreclinicalBiologic

Imaging and Clinical Reports is one of 41 biologic programs targeting Amyotrophic Lateral Sclerosis. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Amyotrophic Lateral SclerosisActive, not recruiting

Amyotrophic Lateral SclerosisPreclinical

Active, not recruiting

Competition

Competitive Landscape

220 competitors in Amyotrophic Lateral Sclerosis

#DrugCompanyPhaseTrials

Tivicay

GSK

Phase 3

2 2

Radicava

Shionogi

Phase 3

2 3

Simdax

Orion Corporation, Orion Pharma

Phase 3

1 4

Ultomiris

Robitussin

Lithobid

SSolvay Pharmaceuticals

Phase 3

3 7

Minocin

TTriax

Phase 3

2 8

Sodium Valproate

AstraZeneca

Phase 3

1 9

BOTULINUM TOXIN TYPE B

Eisai

Phase 3

1 10

Colcrys

Alnylam Pharmaceuticals

Phase 2

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q3 2028

Active, not recruiting

Amyotrophic Lateral Sclerosis

NCT07143656

Clinical

Trials by Indication[1]

Amyotrophic Lateral Sclerosis1 trial

Amyotrophic Lateral Sclerosis: A Multicenter Retrospective Observational Registry

Active, not recruiting·BBiocells Medical··NCT07143656·36 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Imaging and Clinical Reports. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Imaging and Clinical Reports compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Imaging and Clinical Reports. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Biocells Medical company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Biologic[2]
Highest Phase: Preclinical[1]
Company: BBiocells Medical

Imaging and Clinical Reports

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q3 2028

Trials by Indication[1]

Amyotrophic Lateral Sclerosis1 trial

References

Drug Info

Quick Facts

Related News